543 related articles for article (PubMed ID: 20091535)
1. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
[TBL] [Abstract][Full Text] [Related]
2. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
[TBL] [Abstract][Full Text] [Related]
3. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
[TBL] [Abstract][Full Text] [Related]
6. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
[TBL] [Abstract][Full Text] [Related]
7. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
8. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
[TBL] [Abstract][Full Text] [Related]
9. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
10. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
[TBL] [Abstract][Full Text] [Related]
11. Lactic acidosis induced by metformin: incidence, management and prevention.
Lalau JD
Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
[TBL] [Abstract][Full Text] [Related]
12. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
[TBL] [Abstract][Full Text] [Related]
13. [Traditional contraindications to the use of metformin -- more harmful than beneficial?].
Holstein A; Egberts EH
Dtsch Med Wochenschr; 2006 Jan; 131(3):105-10. PubMed ID: 16418951
[TBL] [Abstract][Full Text] [Related]
14. A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.
Novita BD; Pranoto A; Wuryani ; Soediono EI; Mertaniasih NM
Indian J Tuberc; 2018 Jul; 65(3):252-256. PubMed ID: 29933869
[TBL] [Abstract][Full Text] [Related]
15. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
16. Adverse event notifications implicating metformin with lactic acidosis in Australia.
Huang W; Castelino RL; Peterson GM
J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
18. Laboratory-Confirmed Metformin-Associated Lactic Acidosis.
Nestor C; Nasim S; Coyle N; Canavan C
Ir Med J; 2019 Sep; 112(8):992. PubMed ID: 31650826
[TBL] [Abstract][Full Text] [Related]
19. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.
Kamber N; Davis WA; Bruce DG; Davis TM
Med J Aust; 2008 Apr; 188(8):446-9. PubMed ID: 18429709
[TBL] [Abstract][Full Text] [Related]
20. [Metformin-associated lactic acidosis precipitated by acute renal failure].
Pertek JP; Vidal S; Mariot J; Galy-Floc'h M; Azoulay E
Ann Fr Anesth Reanim; 2003 May; 22(5):457-60. PubMed ID: 12831972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
